B Kolek

759 total citations
16 papers, 637 citations indexed

About

B Kolek is a scholar working on Molecular Medicine, Pharmacology and Infectious Diseases. According to data from OpenAlex, B Kolek has authored 16 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Medicine, 11 papers in Pharmacology and 5 papers in Infectious Diseases. Recurrent topics in B Kolek's work include Antibiotic Resistance in Bacteria (14 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Bacterial Identification and Susceptibility Testing (4 papers). B Kolek is often cited by papers focused on Antibiotic Resistance in Bacteria (14 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Bacterial Identification and Susceptibility Testing (4 papers). B Kolek collaborates with scholars based in United States. B Kolek's co-authors include J Fung-Tomc, D P Bonner, Beatrice Minassian, E Huczko, Elizabeth Gradelski, Lourdes Valera, Terry M. Stickle, R E Kessler, Lauren M. Aleksunes and Stephen W. Mamber and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and International Journal of Antimicrobial Agents.

In The Last Decade

B Kolek

16 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B Kolek United States	13	307	294	206	173	151	16	637
Axel Dalhoff Germany	13	250 0.8×	348 1.2×	248 1.2×	116 0.7×	201 1.3×	24	780
Elizabeth Gradelski United States	13	261 0.9×	260 0.9×	129 0.6×	135 0.8×	114 0.8×	19	513
E Huczko United States	15	345 1.1×	273 0.9×	356 1.7×	317 1.8×	114 0.8×	20	806
Barbara LeBlanc United States	15	364 1.2×	305 1.0×	177 0.9×	131 0.8×	107 0.7×	45	629
Bonifacio Dewasse United States	14	273 0.9×	264 0.9×	367 1.8×	235 1.4×	130 0.9×	21	678
Dianne B. Hoellman United States	16	308 1.0×	264 0.9×	323 1.6×	216 1.2×	72 0.5×	23	635
Karen Amsler United States	10	233 0.8×	231 0.8×	157 0.8×	257 1.5×	105 0.7×	15	593
Kim Credito United States	16	308 1.0×	255 0.9×	318 1.5×	410 2.4×	140 0.9×	27	776
Beatrice Minassian United States	14	284 0.9×	203 0.7×	323 1.6×	330 1.9×	142 0.9×	18	783
B Slocombe United Kingdom	13	252 0.8×	264 0.9×	198 1.0×	314 1.8×	322 2.1×	31	870

Countries citing papers authored by B Kolek

Since Specialization

Citations

This map shows the geographic impact of B Kolek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Kolek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Kolek more than expected).

Fields of papers citing papers by B Kolek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Kolek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Kolek. The network helps show where B Kolek may publish in the future.

Co-authorship network of co-authors of B Kolek

This figure shows the co-authorship network connecting the top 25 collaborators of B Kolek. A scholar is included among the top collaborators of B Kolek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Kolek. B Kolek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Clark, Junius M., J Fung-Tomc, Beatrice Minassian, et al.. (2002). In Vitro and In Vivo Activities of a Novel Cephalosporin, BMS-247243, against Organisms other than Staphylococci. Antimicrobial Agents and Chemotherapy. 46(4). 1108–1111. 1 indexed citations

Fung-Tomc, J, Junius M. Clark, Beatrice Minassian, et al.. (2002). In Vitro and In Vivo Activities of a Novel Cephalosporin, BMS-247243, against Methicillin-Resistant and -Susceptible Staphylococci. Antimicrobial Agents and Chemotherapy. 46(4). 971–976. 41 indexed citations

Gradelski, Elizabeth, Lourdes Valera, B Kolek, D P Bonner, & J Fung-Tomc. (2001). Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and β-lactams. International Journal of Antimicrobial Agents. 18(1). 43–48. 13 indexed citations

Gradelski, Elizabeth, B Kolek, D P Bonner, et al.. (2001). Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents. International Journal of Antimicrobial Agents. 17(2). 103–107. 34 indexed citations

Fung-Tomc, J, et al.. (2000). In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin. Journal of Antimicrobial Chemotherapy. 45(4). 437–446. 106 indexed citations

Fung-Tomc, J, Elizabeth Gradelski, Lourdes Valera, B Kolek, & D P Bonner. (2000). Comparative Killing Rates of Fluoroquinolones and Cell Wall-Active Agents. Antimicrobial Agents and Chemotherapy. 44(5). 1377–1380. 23 indexed citations

Fung-Tomc, J, Beatrice Minassian, B Kolek, et al.. (2000). Antibacterial Spectrum of a Novel Des-Fluoro(6) Quinolone, BMS-284756. Antimicrobial Agents and Chemotherapy. 44(12). 3351–3356. 142 indexed citations

Fung-Tomc, J, Karen Bush, Beatrice Minassian, et al.. (1997). Antibacterial activity of BMS-180680, a new catechol-containing monobactam. Antimicrobial Agents and Chemotherapy. 41(5). 1010–1016. 27 indexed citations

Kessler, R E, J Fung-Tomc, B Kolek, et al.. (1995). In vitro activity of BMS-181139, a new carbapenem with potent antipseudomonal activity. Antimicrobial Agents and Chemotherapy. 39(2). 380–385. 10 indexed citations

10.

Fung-Tomc, J, Elizabeth Gradelski, B Kolek, et al.. (1995). Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2. Antimicrobial Agents and Chemotherapy. 39(2). 386–393. 10 indexed citations

11.

Fung-Tomc, J, E Huczko, Terry M. Stickle, et al.. (1995). Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides. Antimicrobial Agents and Chemotherapy. 39(2). 533–538. 36 indexed citations

12.

Fung-Tomc, J, E Huczko, Jacques Banville, et al.. (1995). Structure-activity relationships of carbapenems that determine their dependence on porin protein D2 for activity against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 39(2). 394–399. 16 indexed citations

13.

Fung-Tomc, J, Beatrice Minassian, E Huczko, et al.. (1995). In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184. Antimicrobial Agents and Chemotherapy. 39(2). 295–300. 40 indexed citations

14.

Mamber, Stephen W., et al.. (1993). Activity of quinolones in the Ames Salmonella TA102 mutagenicity test and other bacterial genotoxicity assays. Antimicrobial Agents and Chemotherapy. 37(2). 213–217. 63 indexed citations

15.

Fung-Tomc, J, B Kolek, & D P Bonner. (1993). Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 37(6). 1289–1296. 61 indexed citations

16.

Fung-Tomc, J, et al.. (1991). In vitro activities of cefepime alone and with amikacin against aminoglycoside-resistant gram-negative bacteria. Antimicrobial Agents and Chemotherapy. 35(12). 2652–2654. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact